ANDA Time To Approval, First Action Curves Need To Bend
Executive Summary
FDA generics office says improvement will be noticeable soon, but output can’t dramatically increase overnight.
You may also be interested in...
ANDA Approval Times Get Optimistic Estimate In Budget Request
US FDA has historically overestimated generic review performance in budget requests, but recently underestimated the number of ANDAs it expects to approve.
ANDA Approval Times Get Optimistic Estimate In Budget Request
US FDA has historically overestimated generic review performance in budget requests, but recently underestimated the number of ANDAs it expects to approve.
FDA Generics Office To Be Managed By Relative Unknown
Director Uhl’s medical leave puts bioequivalence office head John Peters in the limelight.